News about "unmet medical need in the US"

BeOne Medicines Wins US FDA Approval for Tevimbra-Based Regimen in HER2-Positive Gastroesophageal Cancer

BeOne Medicines Wins US FDA Approval for Tevimbra-Based Regimen in HER2-Positive Gastroesophageal Cancer

Tevimbra, Ziihera and chemotherapy combination improves overall and progression-free survival in first-line treatment of unresectable or metastatic HER2-positive gastroesophageal adenocarcinoma.

Unmet Medical Need In The US | 27/08/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members